Introduction

The Tumor Comprehensive Treatment Center of Foresea Yihe International Medical Center comprises departments such as Oncology, Radiotherapy, Interventional Radiology, Radiology, and Pathology. It collaborates with internal and surgical departments to carry out a multidisciplinary diagnostic and treatment model for tumors. The center has achieved domestically advanced levels in the diagnosis and treatment of various tumors, including head and neck cancer, colorectal cancer, lung cancer, esophageal cancer, brain tumors, and breast cancer. It comprehensively covers the most advanced tumor treatment methods currently available in medical practice, including surgical treatment, chemotherapy, radiotherapy, interventional therapy, targeted therapy, immunotherapy, and local radiofrequency ablation. In the future, the center plans to introduce proton therapy systems to keep pace with the top domestic standards, providing safer and more effective treatment options for tumor patients.

The Tumor Comprehensive Treatment Medical Center is led by President Wang Jianping and Deputy President Huang Yannian. The core team is composed of Director Zhang Weimin from Oncology Department, Director Zheng Jian from Radiotherapy, Director Wang Weizhong from Interventional Radiology, Director Xiong Wenjie from Hematology, Director Zhou Zhiyang from Radiology, and Director Chen Xiaodong from Pathology, with a team of over 100 staff members. The center is equipped with high-end devices such as Elekta linear accelerators, the latest Digital 64 / 128 Slice PET CT Scanner from GE Healthcare, and large DSAs. Relying on these devices and supported by talented personnel, the center provides a strong guarantee for comprehensive and high-end tumor treatment plans.

Treatment and Services

1）Diagnosis and Treatment Scope
Surgical Treatment: Providing radical tumor resection surgery for tumor patients through laparoscopic minimally invasive techniques, intraoperative navigation, etc.
Precision Radiotherapy: Utilizing an intelligent digital control system, high-speed and high-precision integrated multi-leaf collimators, and advanced four-dimensional real-time image acquisition to quickly and flexibly complete precision radiotherapy schemes such as three-dimensional conformal intensity-modulated radiotherapy (IMRT), volumetric modulated arc therapy (VMAT), SRS/SBRT, etc.
Individualized High-Level Chemotherapy: Guided by the NCCN Clinical Practice Guidelines in Oncology and based on evidence-based medicine principles, individualized treatment is tailored in combination with patients' genetic status.
Interventional Therapy: Including Transcatheter arterial chemoembolization (TACE), local radiofrequency ablation, microwave therapy, and other techniques.
Targeted Therapy: At the cellular and molecular level, treatment is carried out on identified tumor-driving genes. Targeted drugs bind to and work by specifically selecting carcinogenic sites, causing specific tumor cell death without affecting surrounding normal tissue cells.
Immunotherapy: Various tumor immunotherapies are carried out to restart the body's immune function against tumors, such as cytokine, molecular vaccines and other molecular therapies, cell vaccines, stem cell transplantation, adoptive cell therapy and other cell therapies, and immunomodulators such as response regulators and immunosuppressants.
Rehabilitation Supportive Care: Through standardized treatment of cancer pain, nutrition and chemotherapy-induced vomiting, we have formed special nursing brands such as pain-free wards and vomiting-free wards.
Genetic Testing: including hereditary cancer risk assessment, providing guidance on chemotherapy, targeted therapy, and immunotherapy, and evaluating the efficacy and risks of chemotherapy drugs.

2）Features
The center introduced international cutting-edge equipment such as the digital PET/CT from GE Healthcare, Elekta linear accelerators, and large DSAs. Leveraging intelligent digital control systems and advanced four-dimensional real-time image acquisition technology, we implement precision radiotherapy schemes including IMRT, VMAT, SRS/SBRT, and more. Additionally, the center introduced a proton therapy system to build a superlative tumor treatment platform. This ensures the safe and precise execution of tumor surgical procedures, radiotherapy, interventional therapy, targeted therapy, and immunotherapy.
Strictly adhering to the international clinical standards of the NCCN Clinical Practice Guidelines in Oncology, the center conducts individualized analyses and chemotherapy in conjunction with patients' genetic profiles. Through multidisciplinary collaboration (MDT), we provide patients with rapid and accurate diagnoses, risk stratification, and personalized high-standard treatment strategies. Furthermore, we offer one-stop integrated medical services ranging from diagnosis, treatment, and rehabilitation to gene testing and risk assessment, ensuring that tumor patients can undergo the entire treatment process with peace of mind.